Multi-protein delivery by nanodiamonds promotes bone formation

Journal of Dental Research

Volumn 92, Issue 11, 2013, Pages 976-981

  Moore, L ^a   Gatica, M ^a   Kim, H ^a   Osawa, E ^b   Ho, D ^c,d  

^a Northwestern University   (United States)

^b SHINSHU UNIVERSITY   (Japan)

^c UCLA SCHOOL OF DENTISTRY   (United States)

^d Engineering IV   (United States)

Author keywords

bioengineering; biomaterials; carbon; drug delivery; nanomedicine; nanoparticle

Indexed keywords

ALKALINE PHOSPHATASE; BIOMATERIAL; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; CARBON; FIBROBLAST GROWTH FACTOR 2; NANODIAMOND; NANOPARTICLE;

ARTICLE; BIOENGINEERING; BIOMATERIALS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; COLLOID; CULTURE TECHNIQUE; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; INFRARED SPECTROSCOPY; MYOBLAST; NANOMEDICINE; OSTEOBLAST; PARTICLE SIZE; PHYSIOLOGY; PROTEIN BINDING; STEM CELL; SURFACE PROPERTY;

BIOENGINEERING; BIOMATERIALS; CARBON; DRUG DELIVERY; NANOMEDICINE; NANOPARTICLE;

ALKALINE PHOSPHATASE; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEIN 2; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLOIDS; DIFFUSION; DRUG DELIVERY SYSTEMS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MYOBLASTS; NANODIAMONDS; OSTEOBLASTS; OSTEOGENESIS; PARTICLE SIZE; PROTEIN BINDING; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STEM CELLS; SURFACE PROPERTIES;

EID: 84886879232     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034513504952     Document Type: Article

References (30)

1. Aframian DJ, Davidowitz T, Benoliel R. The distribution of oral mucosal pH values in healthy saliva secretors. Oral Dis. 2006 ; 12: 420-423
2. Allegrini S, Yoshimoto M, Salles MB, Konig B. Bone regeneration in rabbit sinus lifting associated with bovine BMP. J Biomed Mater Res B Appl Biomater. 2004 ; 68: 127-131
3. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA. 1990 ; 87: 9843-9847
4. Chow EK, Zhang X-Q, Chen M, Lam R, Robinson E, Huang H, et al. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci Transl Med. 2011 ; 3: 73ra21
5. Fujimura K, Bessho K, Okubo Y, Kusumoto K, Segami N, Iizuka T. The effect of fibroblast growth factor-2 on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in rat muscle. Arch Oral Biol. 2002 ; 47: 577-584
6. Gautschi OP, Frey SP, Zellweger R. Bone morphogenetic proteins in clinical applications. ANZ J Surg. 2007 ; 77: 626-631
7. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002 ; 84-A: 2123-2134
8. Hughes-Fulford M, Li CF. The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization. J Orthop Surg Res. 2011 ; 6: 8
9. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 1994 ; 127 (6 Pt 1). 1755-1766
10. Kubota K, Iseki S, Kuroda S, Oida S, Iimura T, Duarte WR, et al. Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone. 2002 ; 31: 465-471
11. Liu Y, Sun K. Protein functionalized nanodiamond arrays. Nanoscale Res Lett. 2010 ; 5: 1045-1050
12. Moore JW, Dionne C, Jaye M, Swain JL. The mRNAs encoding acidic FGF, basic FGF and FGF receptor are coordinately downregulated during myogenic differentiation. Development. 1991 ; 111: 741-748
13. Moore L, Chow EK, Osawa E, Bishop JM, Ho D. Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression. Adv Mater. 2013 ; 25: 3532-3541
14. Moy FJ, Seddon AP, Böhlen P, Powers R. High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy. Biochemistry. 1996 ; 35: 13552-13561
15. Nakamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, Wakitani S. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone. 2005 ; 36: 399-407
16. Ong KL, Villarraga ML, Lau E, Carreon LY, Kurtz SM, Glassman SD. Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine. 2010 ; 35: 1794-1800
17. Scheufler C, Sebald W, Hulsmeyer M. Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. J Mol Biol. 1999 ; 287: 103-115
18. Schliephake H, Aref A, Scharnweber D, Bierbaum S, Roessler S, Sewing A. Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation. Clin Oral Implants Res. 2005 ; 16: 563-569
19. Shimkunas RA, Robinson E, Lam R, Lu S, Xu X, Zhang X-Q, et al. Nanodiamond-insulin complexes as pH-dependent protein delivery vehicles. Biomaterials. 2009 ; 30: 5720-5728
20. Smith AH, Robinson EM, Zhang XQ, Chow EK, Lin Y, Osawa E, et al. Triggered release of therapeutic antibodies from nanodiamond complexes. Nanoscale. 2011 ; 3: 2844-2848
21. Steinmuller-Nethl D, Kloss FR, Najam-Ul-Haq M, Rainer M, Larsson K, Linsmeier C, et al. Strong binding of bioactive BMP-2 to nanocrystalline diamond by physisorption. Biomaterials. 2006 ; 27: 4547-4556
22. Templeton TJ, Hauschka SD. FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFR1. Dev Biol. 1992 ; 154: 169-181
23. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res. 1999 ; 46: 193-202
24. Wei L, Zhang W, Lu H, Yang P. Immobilization of enzyme on detonation nanodiamond for highly efficient proteolysis. Talanta. 2010 ; 80: 1298-1304
25. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988 ; 242: 1528-1534
26. Yang L, Sheldon BW, Webster TJ. Orthopedic nano diamond coatings: control of surface properties and their impact on osteoblast adhesion and proliferation. J Biomed Mater Res A. 2009 ; 91: 548-556
27. Yeap WS, Tan YY, Loh KP. Using detonation nanodiamond for the specific capture of glycoproteins. Anal Chem. 2008 ; 80: 4659-4665
28. Zhang Q, Mochalin VN, Neitzel I, Knoke IY, Han J, Klug CA, et al. Fluorescent PLLA-nanodiamond composites for bone tissue engineering. Biomaterials. 2011 ; 32: 87-94
29. Zhang S, Doschak MR, Uludag H. Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles. Biomaterials. 2009 ; 30: 5143-5155
30. Zhang X, Hu W, Li J, Tao L, Wei Y. A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond. Toxicol Res. 2012 ; 1: 62-68